The U.S. Internal Revenue Service hit Boston Scientific (NYSE:BSX) with another huge tax bill over its 2006 acquisition of pacemaker firm Guidant Corp.
The latest tab, for $581 million plus interest and penalties, comes out of an IRS audit of Guidant’s books for 2004 through 2006, according to a regulatory filing.